Variant report

Variant	esv16621
Chromosome Location	chr16:72318979-72319969
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:72318452..72319025-chr7:141320935..141321919,2	MCF-7	breast:
2	chr16:72319110..72320804-chr16:72323205..72325965,2	MCF-7	breast:
3	chr16:72316333..72319342-chr16:72319918..72322341,3	K562	blood:
4	chr16:72316333..72319342-chr16:72319918..72322341,3	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PMFBP1-3	chr16:72319278-72319328	NONHSAT143559
2	lnc-PMFBP1-3	chr16:72319278-72319352	ENSG00000250143

No data

Variant related genes	Relation type
ZBTB24	miRNA target sites

Extended variants
information (count: 67 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:67 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543077568	chr16:72318979-72318980	Enhancers Weak transcription Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs373562920	chr16:72318980-72318981	Enhancers Weak transcription Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs561202351	chr16:72319019-72319020	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs111737056	chr16:72319037-72319038	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs540621197	chr16:72319045-72319046	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs138046075	chr16:72319046-72319047	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs375735509	chr16:72319048-72319049	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs565624346	chr16:72319070-72319071	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs532814824	chr16:72319074-72319075	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs550910069	chr16:72319081-72319082	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs373830574	chr16:72319083-72319084	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs530212023	chr16:72319090-72319091	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs529729075	chr16:72319093-72319094	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs377170568	chr16:72319099-72319100	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs189843636	chr16:72319101-72319102	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs533592421	chr16:72319114-72319115	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs552015165	chr16:72319123-72319124	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs570421489	chr16:72319128-72319129	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs142019366	chr16:72319137-72319138	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs556105100	chr16:72319139-72319140	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs180994110	chr16:72319149-72319150	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs541643079	chr16:72319163-72319164	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs114018341	chr16:72319164-72319165	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs114743363	chr16:72319172-72319173	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs146142046	chr16:72319198-72319199	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs532878969	chr16:72319206-72319207	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs112588584	chr16:72319226-72319227	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs142404322	chr16:72319230-72319231	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs145937662	chr16:72319248-72319249	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs530361640	chr16:72319264-72319265	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs139535586	chr16:72319267-72319268	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs116712049	chr16:72319303-72319304	Enhancers Weak transcription Flanking Active TSS Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs527343045	chr16:72319314-72319315	Enhancers Weak transcription Flanking Active TSS Strong transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs551768148	chr16:72319354-72319355	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs115451699	chr16:72319376-72319377	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs545869738	chr16:72319382-72319383	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs34564050	chr16:72319384-72319385	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs537418860	chr16:72319399-72319400	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs371119699	chr16:72319441-72319442	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs149687496	chr16:72319482-72319483	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs145577302	chr16:72319493-72319494	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs78909858	chr16:72319516-72319517	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs573390908	chr16:72319539-72319540	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs202149753	chr16:72319549-72319550	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs185026620	chr16:72319557-72319558	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs148446819	chr16:72319560-72319561	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs577345831	chr16:72319598-72319599	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs374611895	chr16:72319603-72319604	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs142700689	chr16:72319615-72319616	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs563244194	chr16:72319641-72319642	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute myeloid leukemia	16864856	CNVD
Infiltrating lobular breast cancer	19191266	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Medulloblastoma	16783165	CNVD
Neuroblastoma	21899760	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21509527	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD

Chromatin state (count:53 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:72302600-72332000	Weak transcription	Primary B cells from cord blood	blood
2	chr16:72313400-72323000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr16:72315600-72353600	Weak transcription	Dnd41	blood
4	chr16:72315800-72320600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr16:72316000-72319600	Weak transcription	Primary neutrophils fromperipheralblood	blood
6	chr16:72316000-72323400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr16:72316600-72334800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr16:72317000-72319000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr16:72317400-72319000	Strong transcription	Primary hematopoietic stem cells short term culture	blood
10	chr16:72317400-72331800	Weak transcription	Primary hematopoietic stem cells	blood
11	chr16:72318000-72319600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr16:72318200-72319000	Genic enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr16:72318200-72319800	Enhancers	H1 Cell Line	embryonic stem cell
14	chr16:72318200-72320000	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr16:72318200-72320000	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr16:72318200-72320000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr16:72318200-72320200	Enhancers	iPS-15b Cell Line	embryonic stem cell
18	chr16:72318200-72324200	Enhancers	HMEC	breast
19	chr16:72318400-72319000	Enhancers	NHEK	skin
20	chr16:72318400-72319200	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr16:72318400-72319400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr16:72318400-72319600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr16:72318400-72320000	Enhancers	H9 Cell Line	embryonic stem cell
24	chr16:72318400-72320000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr16:72318600-72319200	Enhancers	iPS-18 Cell Line	embryonic stem cell
26	chr16:72318600-72320000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
27	chr16:72318600-72324800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr16:72318600-72329200	Weak transcription	HepG2	liver
29	chr16:72318800-72319000	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr16:72318800-72319400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr16:72318800-72319600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr16:72318800-72320000	Enhancers	HUES64 Cell Line	embryonic stem cell
33	chr16:72318800-72320600	Weak transcription	Thymus	Thymus
34	chr16:72318800-72323600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr16:72319000-72319800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
36	chr16:72319000-72319800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr16:72319000-72320000	Weak transcription	NHEK	skin
38	chr16:72319000-72320200	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr16:72319000-72320600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
40	chr16:72319200-72319600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
41	chr16:72319200-72320000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
42	chr16:72319200-72321000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr16:72319400-72320000	Enhancers	Monocytes-CD14+_RO01746	blood
44	chr16:72319400-72320000	Enhancers	Osteobl	bone
45	chr16:72319400-72320200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
46	chr16:72319400-72320800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr16:72319600-72319800	Enhancers	Primary neutrophils fromperipheralblood	blood
48	chr16:72319600-72320200	Enhancers	HUES48 Cell Line	embryonic stem cell
49	chr16:72319600-72320800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr16:72319600-72324800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links